[go: up one dir, main page]

ATE174963T1 - Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum - Google Patents

Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum

Info

Publication number
ATE174963T1
ATE174963T1 AT91913838T AT91913838T ATE174963T1 AT E174963 T1 ATE174963 T1 AT E174963T1 AT 91913838 T AT91913838 T AT 91913838T AT 91913838 T AT91913838 T AT 91913838T AT E174963 T1 ATE174963 T1 AT E174963T1
Authority
AT
Austria
Prior art keywords
pct
falciparum
expression
associated protein
rhoptry
Prior art date
Application number
AT91913838T
Other languages
English (en)
Inventor
Allan James Saul
Juan Anton Cooper
David Owen Irving
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Application granted granted Critical
Publication of ATE174963T1 publication Critical patent/ATE174963T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91913838T 1990-08-02 1991-08-01 Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum ATE174963T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK152590 1990-08-02

Publications (1)

Publication Number Publication Date
ATE174963T1 true ATE174963T1 (de) 1999-01-15

Family

ID=3774860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913838T ATE174963T1 (de) 1990-08-02 1991-08-01 Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum

Country Status (10)

Country Link
US (1) US5573943A (de)
EP (1) EP0541629B1 (de)
JP (1) JPH05508996A (de)
AT (1) ATE174963T1 (de)
CA (1) CA2088478C (de)
DE (1) DE69130675T2 (de)
IL (1) IL99034A (de)
MY (1) MY107451A (de)
WO (1) WO1992002623A1 (de)
ZA (1) ZA916106B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013671A1 (en) * 2000-05-31 2004-01-22 Institut Pasteur Antibodies which bind to proteins involved in cyttoadhesion of Plasmodlum falciparum ring-stage-infected erythrocytes
WO2001092321A2 (en) * 2000-05-31 2001-12-06 Institut Pasteur Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
WO2008055254A2 (en) * 2006-11-01 2008-05-08 Board Of Regents, The University Of Texas System Formulations and methods for oral delivery of proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116755A (en) * 1985-12-24 1992-05-26 Kemp David J Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum

Also Published As

Publication number Publication date
EP0541629B1 (de) 1998-12-23
EP0541629A1 (de) 1993-05-19
CA2088478A1 (en) 1992-02-03
MY107451A (en) 1995-12-31
IL99034A (en) 1996-10-16
EP0541629A4 (en) 1993-12-29
CA2088478C (en) 2002-06-11
WO1992002623A1 (en) 1992-02-20
JPH05508996A (ja) 1993-12-16
US5573943A (en) 1996-11-12
ZA916106B (en) 1992-06-24
DE69130675D1 (de) 1999-02-04
DE69130675T2 (de) 1999-10-14

Similar Documents

Publication Publication Date Title
GB8625435D0 (en) Human apolipoprotein ai
ATE368053T1 (de) Antimikrobielle peptide
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
ATE215124T1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ATE292685T1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
ATE280227T1 (de) Epitope von stress proteinen
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
NO970113D0 (no) Kollagenbindende protein eller polypeptid
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE69017352D1 (de) An HIV relatierte Peptide.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
ATE112290T1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DK128687A (da) Proteiner samt deres fremstilling og anvendelse
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
KR910001051A (ko) 결실형 알파 아밀라제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties